StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Kunal Bothra

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byKunal BothraHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via ET Now

Entry₹5,044.5Inferred
Target₹5,200
Total upside +3.08% (call closed)
Stop loss₹4,800-4.85% risk
At expiry₹5,0122 Sept 2026, 3:30 pm
Expired-0.64%auction close
Follow Kunal Bothra for new calls(30% target hit, 275 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 150 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
8 supporting2 neutral0 opposing
Supports the BUY call (8)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·28 Aug · 4d ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·28 Aug · 5d ago

Torrent Pharma Plans Drug Discovery Return After Decade of M&A

NewsGoogle News·22 Aug · 1w ago

(opens in new tab)

Torrent Pharma Share Price: 10 साल बाद कंपनी का बड़ा फैसला! दवा रिसर्च में वापसी, क्या निवेशकों को होगा फायदा?

NewsGoogle News·22 Aug · 1w ago

(opens in new tab)

Ruby Mills sells The Ruby 33rd floor to Torrent Pharma for ₹124.08 crore

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Torrent Pharma Share: Q1 முடிவுகள்! வருவாய் ஜோர், லாபம் மிதமோ?

NewsGoogle News·17 Aug · 2w ago

(opens in new tab)

Torrent Pharma assigned ESG rating of 70 by NSE Sustainability

NewsGoogle News·11 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from Kunal Bothra

Every call and its outcome